• The Quinn Partnership Phlex Some Muscle on Latest Inflexion Deal

The Quinn Partnership Phlex Some Muscle on Latest Inflexion Deal

The Quinn Partnership, the UK’s leading provider of Management Due Diligence to the private equity market has advised mid-market private equity investor Inflexion on the buy-out of Phlexglobal, the market leading healthcare support services company.

Operating in the UK and US market, Phlexglobal deliver a niche service across the pharmaceutical, biotechnology, medical device and healthcare industries. Established in 1997, Phlexglobal have strong relationships with the majority of the top ten global pharmaceutical companies and employ circa 200 employees in delivering a support service for all administrative and operational aspects of the clinical trial process, ranging from document management, and pre and post inspection support to tracking systems support, archiving and training.

Richard Swann, Investment Director at Inflexion Private Equity commented: “Phlexglobal operates in an interesting niche market and is an excellent example of the type of business that Inflexion seeks to invest in, offering a superior service and product to its customers. We look forward to working with the experienced management team to drive further growth in the company.”

Speaking about the deal, Paul Quinn, Director at The Quinn Partnership said, "Phlexglobal have developed an impressive management team. Supported by Inflexions expertise this will present a very compelling proposition in a competitive and highly specialised market."

Copyright The Quinn Partnership